$RPTP NASH Play huge RP103 for Pediatric Non-alcoholic Steatohepatitis (NASH): In the Phase 2b pediatric NASH (CyNCh) trial, all 169 enrolled patients have completed the Week 52 visit as of January 2015. The company anticipates Phase 2b data release by the National Institute of Diabetes and Digestive and Kidney Diseases, or NIDDK, in 2H15.
MAY 14 calls active
Always place Stop Loss order after buying a stock to minimize losses.I lost 100k by not doing so.We learn from our mistakes or may be from others who have done those.
Singh